Awm Investment Company, Inc. Renovo Rx, Inc. Transaction History
Awm Investment Company, Inc.
- $697 Million
- Q2 2025
A detailed history of Awm Investment Company, Inc. transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Awm Investment Company, Inc. holds 1,870,225 shares of RNXT stock, worth $2.06 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
1,870,225
Previous 2,285,000
18.15%
Holding current value
$2.06 Million
Previous $2.26 Million
9.11%
% of portfolio
0.35%
Previous 0.36%
Shares
2 transactions
Others Institutions Holding RNXT
# of Institutions
28Shares Held
9.77MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$3.81 Million2.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.83 Million0.0% of portfolio
-
Bank Of The West975KShares$1.07 Million0.27% of portfolio
-
Bleichroeder LP New York, NY500KShares$550,0000.21% of portfolio
-
Geode Capital Management, LLC Boston, MA354KShares$388,9630.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.97M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...